Cargando…

Tetrahydrohyperforin: a neuroprotective modified natural compound against Alzheimer's disease

Detalles Bibliográficos
Autores principales:	Montecinos-Oliva, Carla, Schüller, Andreas, Inestrosa, Nibaldo C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424742/ https://www.ncbi.nlm.nih.gov/pubmed/26170810 http://dx.doi.org/10.4103/1673-5374.155420

Ejemplares similares

Tetrahydrohyperforin (IDN5706) targets the endoplasmic reticulum for autophagy activation: potential mechanism for Alzheimer's disease therapy
por: González, Alexis, et al.
Publicado: (2016)

Wnt-related SynGAP1 is a neuroprotective factor of glutamatergic synapses against Aβ oligomers
por: Codocedo, Juan F., et al.
Publicado: (2015)

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
por: Friedli, María Jesús, et al.
Publicado: (2021)

Tetrahydrohyperforin Inhibits the Proteolytic Processing of Amyloid Precursor Protein and Enhances Its Degradation by Atg5-Dependent Autophagy
por: Cavieres, Viviana A., et al.
Publicado: (2015)

Tetrahydrohyperforin and Octahydrohyperforin Are Two New Potent Inhibitors of Angiogenesis
por: Martínez-Poveda, Beatriz, et al.
Publicado: (2010)

Diterpenes and the crosstalk with the arachidonic acid pathways, relevance in neurodegeneration
por: Zolezzi, Juan M., et al.
Publicado: (2019)

Hormetic-Like Effects of L-Homocysteine on Synaptic Structure, Function, and Aβ Aggregation
por: Montecinos-Oliva, Carla, et al.
Publicado: (2020)

Is L-methionine a trigger factor for Alzheimer’s-like neurodegeneration?: Changes in Aβ oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type mice
por: Tapia-Rojas, Cheril, et al.
Publicado: (2015)

Tetrahydrohyperforin prevents articular cartilage degeneration and affects autophagy in rats with osteoarthritis
por: Zhang, Jinling, et al.
Publicado: (2018)

Neuroprotective effect of antioxidant compounds
por: Skouta, Rachid
Publicado: (2016)

The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease
por: Inestrosa, Nibaldo C, et al.
Publicado: (2008)

Wnt/TLR Dialog in Neuroinflammation, Relevance in Alzheimer’s Disease
por: Zolezzi, Juan M., et al.
Publicado: (2017)

Tetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing
por: Inestrosa, N C, et al.
Publicado: (2011)

Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer's disease
por: Tapia-Rojas, Cheril, et al.
Publicado: (2018)

Lithium Enhances Hippocampal Glucose Metabolism in an In Vitro Mice Model of Alzheimer’s Disease
por: Gherardelli, Camila, et al.
Publicado: (2022)

Menopause and development of Alzheimer’s disease: Roles of neural glucose metabolism and Wnt signaling
por: Villaseca, Paulina, et al.
Publicado: (2022)

Presymptomatic Treatment With Andrographolide Improves Brain Metabolic Markers and Cognitive Behavior in a Model of Early-Onset Alzheimer’s Disease
por: Cisternas, Pedro, et al.
Publicado: (2019)

On cognitive ecology and the environmental factors that promote Alzheimer disease: lessons from Octodon degus (Rodentia: Octodontidae)
por: Rivera, Daniela S., et al.
Publicado: (2016)

Resistant and Resilient mutations in protection against familial Alzheimer’s disease: learning from nature
por: Sepulveda-Falla, Diego
Publicado: (2023)

Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer’s Disease
por: Dinamarca, Margarita C., et al.
Publicado: (2012)

Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target
por: Lazarin-Bidóia, Danielle, et al.
Publicado: (2022)

Disruption of Glucose Metabolism in Aged Octodon degus: A Sporadic Model of Alzheimer's Disease
por: Cisternas, Pedro, et al.
Publicado: (2021)

Finding effective combinations of compounds to prevent Alzheimer’s disease
por: Dhakal, Sudip, et al.
Publicado: (2022)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Interactions of AChE with Aβ Aggregates in Alzheimer’s Brain: Therapeutic Relevance of IDN 5706
por: Carvajal, Francisco J., et al.
Publicado: (2011)

Long-term social isolation stress exacerbates sex-specific neurodegeneration markers in a natural model of Alzheimer’s disease
por: Oliva, Carolina A., et al.
Publicado: (2023)

Neuroprotective effects of metalosalen complexes against oxidative stress
por: Rouco, Lara, et al.
Publicado: (2020)

Neuroactive alkaloids that modulate the neuronal nicotinic receptor and provide neuroprotection in an Alzheimer's disease model: the case of Teline monspessulana
por: Fuentealba, Jorge, et al.
Publicado: (2014)

Signaling pathway cross talk in Alzheimer’s disease
por: Godoy, Juan A, et al.
Publicado: (2014)

Neuroprotective Natural Products for Alzheimer’s Disease
por: Chen, Xin, et al.
Publicado: (2021)

State and perspectives on flavonoid neuroprotection against aminochrome-induced neurotoxicity
por: Silva, Victor, et al.
Publicado: (2021)

Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases
por: Mohd Sairazi, Nur Shafika, et al.
Publicado: (2020)

Metal and complementary molecular bioimaging in Alzheimer's disease
por: Braidy, Nady, et al.
Publicado: (2014)

Interferon-gamma and neuropathy: balance between pain and neuroprotection
por: Ferrara, Valentina, et al.
Publicado: (2022)

Wnts in adult brain: from synaptic plasticity to cognitive deficiencies
por: Oliva, Carolina A., et al.
Publicado: (2013)

Alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs
por: Zolezzi, Juan M., et al.
Publicado: (2014)

Mens sana in corpore sano: lifestyle changes modify astrocytes to contain Alzheimer’s disease
por: Augusto-Oliveira, Marcus, et al.
Publicado: (2021)

Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer’s disease
por: Balaj, Allison R., et al.
Publicado: (2023)

Inflammation context in Alzheimer’s disease, a relationship intricate to define
por: Novoa, Catalina, et al.
Publicado: (2022)

The neuroprotective effects of the anti-diabetic drug linagliptin against Aβ-induced neurotoxicity
por: Lin, Chih-Li, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6pb0se3tojmqngrcbtg1g2f86i